Shares of Hinge Health rose Monday after Wall Street analysts backed the stock, which remains above the price at which the ...

The digital health startup says it secured the fresh capital to update its valuation and finance acquisitions.

Many healthcare experts are calling Omada Health and Hinge Health's IPO debuts a success, though it's still early days.

Hinge Health (NYSE:HNGE) stock gains as Wall Street issues bullish ratings post-IPO citing its growth prospects. Read more here.

Analysts initiate coverage of Hinge Health with Buy ratings, citing strong tech, recurring revenue, and a growing $18.5 ...

“At the same time, an IPO isn’t a destination; it’s a waypoint. Expectations only go up from here.” Rock Health is an investor in Omada, but not Hinge. The most “anxious period” will ...

Sword Health, which launched 10 years ago, initially focused on virtual musculoskeletal care and then expanded into pelvic ...

Digital therapeutics (DTx) developer Hinge Health has published a new prospectus for an initial public offering (IPO) in the US, shrugging off the weakness in stock markets caused by President ...

Still, the Chime IPO is being celebrated as a win for the company—and more importantly, as a clear signal that the public ...

Salesforce Inc, PepsiCo Inc, FTSE 350 Aerospace & Defense, Skechers USA Inc. Read 's Market Analysis on Investing.com ...

The private equity firm is making multibillion dollar bets in healthtech and giving healthcare investors a new exit route ...

Fintech company Chime said on Wednesday it raised $864 million in its initial public offering (IPO) after pricing shares at ...